Hexahydropyrimidines. V. A study of 2-substituted 1,3-bis(alpha-cyanobenzyl)-hexahydropyrimidines and 2-substituted 1,3-bis(alpha-cyano-p-methoxybenzyl)-hexahydropyrimidines as prospective antitumor agents.
D000818:Animals; D000970:Antineoplastic Agents; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002626:Chemistry, Pharmaceutical; D046508:Culture Techniques; D003486:Cyanides / Q000494:pharmacology*; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D011743:Pyrimidines / Q000494:pharmacology*; D012510:Sarcoma 180 / Q000188:drug therapy
D000970:Antineoplastic Agents; D003486:Cyanides; D011743:Pyrimidines